1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Follicular Lymphoma Drug Profiles and Clinical Trials-Global Trends and Analysis Review, H2 2017

Follicular Lymphoma Drug Profiles and Clinical Trials-Global Trends and Analysis Review, H2 2017

  • January 2018
  • 368 pages
  • ID: 5281805
  • Format: PDF
  • By VPAResearch

Summary

Table of Contents

Search Inside

Lymphoma is a cancer type where uncontrollable growth of lymphocytes (WBCs) initiating from lymph glands or lymphatic tissue or other parts of the lymphatic system, including bone marrow, tonsils, testicles, spleen and lymph nodes.

This excess growth of lymphocytes often accumulates in lymph nodes. Though this accumulation can occur in any body part, commonly affected parts are armpits, neck and groin and rarely in lungs or bones.

The non-inheritable and non-contageous disease is one of the common types of cancer but can be treated with patients’ life expectancy remaining quite large post-treatment.

Genomic alterations in lymphocytes cause damage to the lifecycle of these cells, boosting the cell division rate or affecting the death period. However, causes for such gene changes are yet to be determined.

Phases-

Phases of Lymphoma cancer-
-Single group of lymph nodes (above or below diaphragm)
-Multiple group of lymph nodes are affected(above or below diaphragm)
-Expands to both sides of diaphragm
-Expands to bone marrow or other body parts

Types of Lymphoma Cancer-
Though two types of Lymphoma are defined, it is often difficult to determine the exact sub-type of Lymphoma.

* Hodgkin Lymphoma
In Hodgkin Lymphoma, the cancer cells called Reed-Sternberg (RS) cells, have a characteristic appearance under microscope.

Further subtypes-
Nodular Sclerosis: Lymph nodes contain Reed-Sternberg cells mixed with normal white blood cells

Mixed Cellularity: Lymph nodes contain several Reed-Sternberg cells in addition to several other cell types

Lymphocyte-rich: Lymph nodes contain several normal- appearing lymphocytes and classic Reed-Sternberg cells

Lymphocyte-depleted: Lymph nodes contain large volume of Reed-Sternberg cells and few normal lymphocytes

Nodular lymphocyte-predominant Hodgkin lymphoma: Lymph nodes contain several abnormal B cells and Reed-Sternberg cells are rarely observed

* Non-Hodgkin Lymphoma
Unlike Hodgkin Lymphoma, the cancer cells called Reed-Sternberg cells are absent in this subtype of Lymphoma

High grade NHL

* B-cell NHL Lymphoma
Diffuse large B-cell (DLBCL): Abnormal growth of large B-Cells in different body parts

Intravascular B-Cell: Occurs due to explosion of lymphocytes within tiny vessels with no involvement of the organ parenchyma

Primary mediastinal large B-cell: Large neoplastic cells with B-cell derivation are observed

Burkitt: Most aggressive form, classified as endemic (African) type, sporadic type and HIV related

Primary central nervous system: DLBCL sub-type affecting the brain and or spinal cord

* T-cell NHL Lymphoma
Peripheral T-cell (PTCL NOS): Abnormal growth of T-cells which are not specified under any category

Anaplastic large cell: It can occur in the skin or in other organs throughout the body

Angioimmunoblastic T-cell: the body’s immune system does not recognize, and consequently destroys, its own cells and tissues

Enteropathy-associated: occurs in the intestines and is mostly associated with celiac disease

Nasal-type NK/T-cell: Natural killer cells often affecting the nasal area, trachea, gastrointestinal tract, or skin

Hepatosplenic T-cell: Abnormal growth of T-cells in liver or spleen

Lymphoblastic: The T-cells outgrow in number when a bone marrow cell develops alterations in its gene code

Low Grade NHL
Follicular: B-cells are affected; Enlargement of the lymph nodes in the neck, underarm, stomach, groin

Small lymphocytic: B-lymphocytes, with enlarged nodes affecting neck, armpit or groin

Lympho-plasmacytic: Enlarged cells make varying volumes of immunoglobin M protein in the blood, making it thick (condition referred to as Waldenstrom macroglobulinemi)

MALT Lymphoma (Gastric and Non-gastric): mucosa-associated lymphoid tissue (MALT) starts outside lymph nodes, usually in lymphatic tissue in the mucous membranes or tissues lining organs

Splenic marginal zone: The NHL sub-type affects spleen, bone marrow and blood

Nodal marginal zone: Mostly occurs in lymph nodes and rarely in spleen or bone marrow
Follicular Lymphoma clinical trials report from VPA Research provides comprehensive analysis and trends in global Follicular Lymphoma disease clinical trials. The research work analyzes the evolution of Follicular Lymphoma clinical trial trends across countries and regions.

The report focuses on drugs and therapies being evaluated for Follicular Lymphoma treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner offering quick access to Follicular Lymphoma clinical trials.

Major drugs under development in Follicular Lymphoma are provided in the report along with their details of Mechanism of Action, Route of Administration, Target, therapy, molecule and class.

Scope of the Report-
- Number of Follicular Lymphoma clinical trials across regions- Asia and Oceania, Europe, Middle East Africa and Americas
- Trial information by Phase and Subjects recruited
- Trial information by status, type, sponsor type
- Drugs used for treatment of Follicular Lymphoma
- Both observational and interventional trials analyzed
- Success rates of trials are analyzed
- Trends in enrollment over the past ten years identified
- Leading sponsors of Follicular Lymphoma clinical trials worldwide are listed

Reasons to Buy-
- Track competition and design competitive advantages
- Identify right partners to associate with for further research
- Evaluate potential opportunities available in further clinical trials of the disease
- Formulate business development strategies through success rates of clinical trials
- Identify quick markets for recruiting subjects based on trials count by each market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
MAP Kinase Interacting Serine/Threonine Protein Kinase 2 - Pipeline Review, H2 2019

MAP Kinase Interacting Serine/Threonine Protein Kinase 2 - Pipeline Review, H2 2019

  • $ 3500
  • November 2019

MAP Kinase Interacting Serine/Threonine Protein Kinase 2 - Pipeline Review, H2 2019SummaryAccording to the recently published report ’MAP Kinase Interacting SerineThreonine Protein Kinase 2 - Pipeline ...

Tumor Necrosis Factor Receptor Superfamily Member 5 - Pipeline Review, H2 2019

Tumor Necrosis Factor Receptor Superfamily Member 5 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019

Tumor Necrosis Factor Receptor Superfamily Member 5 - Pipeline Review, H2 2019SummaryTumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Recepto ...

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 - Pipeline Review, H2 2019

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 - Pipeline Review, H2 2019

  • $ 3500
  • November 2019

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 - Pipeline ...


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on